$ACCA Acacia Diversified Holdings, Inc. (ACCA) Reports on

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams stocksonhighalert #51974
263
$ACCA Acacia Diversified Holdings, Inc. (ACCA) Reports on Sponsorship of the Largest Neuroscience Meeting in Europe this Year - FENS Regional Meeting 2019 (FRM2019)

CLEARWATER, Fla., Aug. 19, 2019 /PRNewswire/ -- Acacia Diversified Holdings, Inc. (ACCA – OTCQB, www.Acaciadiversifiedholdings.com ) is pleased to announce that we were among the sponsors of the FENS Regional Meeting 2019 (FRM2019), the largest neuroscience meeting in Europe this year https://www.fensfrm2019.rs/, which was held in Belgrade, Serbia, July 10-13, 2019. The FRM2019 was jointly organized by three National Neuroscience Societies under the auspices of FENS (Federation of European Neuroscience Societies, https://www.fens.org/), the main organization for neuroscience in Europe representing close to 22,000 European neuroscientists. The Organizers expected around 1000 participants from all around the world (at the moment from 53 countries confirmed, and over 450 abstracts accepted), including the European region. Experts of different backgrounds took part in this meeting: scientists, physicians, psychologists and neuropsychologists, therapists, social workers and other professionals involved in the field of neuroscience. An attractive scientific program showcasing the state-of-the-art neuroscience resulted in a meeting at its highest level, with a very impressive line-up of plenary lectures, symposia with the most prominent speakers from 23 countries and a highly attractive number of special events.

Rick Pertile, President/CEO of Acacia Diversified Holdings, Inc. said: "Given that ACCA produces a wide range of products that may have potential as therapeutic strategies for many neurodegenerative and neurological diseases we wanted to support the most recent discoveries in neuroscience with translational potential that were presented at the FRM2019 and in that way boost the advancement of neuroscience globally."

More updates will follow shortly.

Safe Harbor Statement

Information in this filing may contain statements about future expectations, plans, prospects or performance of Acacia Diversified Holdings, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. ACCA Corporation cautions you that any forward-looking information provided by or on behalf of Acacia Diversified Holdings, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Acacia Diversified Holdings, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Acacia Diversified Holdings, Inc.'s control. In addition to those discussed in Acacia Diversified Holdings, Inc.'s press releases, public filings, and statements by Acacia Diversified Holdings, Inc.'s management, including, but not limited to, Acacia Diversified Holdings, Inc.'s estimate of the sufficiency of its existing capital resources, Acacia Diversified Holdings, Inc.'s ability to raise additional capital to fund future operations, ACCA Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Acacia Diversified Holdings, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Acacia Diversified Holdings, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

Cision View original content:http://www.prnewswire.com/news-releases/acacia-diversified-holdings-inc-acca-reports-on-sponsorship-of-the-largest-neuroscience-meeting-in-europe-this-year---fens-regional-meeting-2019-frm2019-300903972.html

SOURCE Acacia Diversified Holdings, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles